Figure 2
Figure 2. Kaplan-Meier survival estimates in patients with symptomatic KSHV-MCD receiving R-Dox. (A) Event-free survival; (B) overall survival.

Kaplan-Meier survival estimates in patients with symptomatic KSHV-MCD receiving R-Dox. (A) Event-free survival; (B) overall survival.

Close Modal

or Create an Account

Close Modal
Close Modal